Cassandre Victor-Vega's research topics

Cassandre Victor-Vega

Concepts (23)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Cassandre Victor-Vega's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Cassandre Victor-Vega has written about over time.

Administration, Topical, 1 publications between 2002 and 2002, average publication date February 2002. Drug Evaluation, Preclinical, 1 publications between 2002 and 2002, average publication date February 2002. Gels, 1 publications between 2002 and 2002, average publication date February 2002. Mice, 1 publications between 2002 and 2002, average publication date February 2002. Mice, Inbred BALB C, 1 publications between 2002 and 2002, average publication date February 2002. Platelet-Derived Growth Factor, 1 publications between 2002 and 2002, average publication date February 2002. Proto-Oncogene Proteins c-sis, 1 publications between 2002 and 2002, average publication date February 2002. Purinergic P1 Receptor Agonists, 1 publications between 2002 and 2002, average publication date February 2002. Recombinant Proteins, 1 publications between 2002 and 2002, average publication date February 2002. Time Factors, 1 publications between 2002 and 2002, average publication date February 2002. Wound Healing, 1 publications between 2002 and 2002, average publication date February 2002. Adenosine, 2 publications between 2002 and 2005, average publication date July 2003. Dose-Response Relationship, Drug, 2 publications between 2002 and 2005, average publication date July 2003. Phenethylamines, 2 publications between 2002 and 2005, average publication date July 2003. Receptor, Adenosine A2A, 2 publications between 2002 and 2005, average publication date July 2003. Down-Regulation, 1 publications between 2005 and 2005, average publication date January 2005. Endothelium, Vascular, 1 publications between 2005 and 2005, average publication date January 2005. Neovascularization, Physiologic, 1 publications between 2005 and 2005, average publication date January 2005. Thrombospondin 1, 1 publications between 2005 and 2005, average publication date January 2005.

Administration, Topical
Drug Evaluation, Preclinical
Gels
Mice
Mice, Inbred BALB C
Platelet-Derived Growth Factor
Proto-Oncogene Proteins c-sis
Purinergic P1 Receptor Agonists
Recombinant Proteins
Time Factors
Wound Healing
Adenosine
Dose-Response Relationship, Drug
Phenethylamines
Receptor, Adenosine A2A
Down-Regulation
Endothelium, Vascular
Neovascularization, Physiologic
Thrombospondin 1

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Administration, Topical	1	2002	2002	February 2002
Drug Evaluation, Preclinical	1	2002	2002	February 2002
Gels	1	2002	2002	February 2002
Mice	1	2002	2002	February 2002
Mice, Inbred BALB C	1	2002	2002	February 2002
Platelet-Derived Growth Factor	1	2002	2002	February 2002
Proto-Oncogene Proteins c-sis	1	2002	2002	February 2002
Purinergic P1 Receptor Agonists	1	2002	2002	February 2002
Recombinant Proteins	1	2002	2002	February 2002
Time Factors	1	2002	2002	February 2002
Wound Healing	1	2002	2002	February 2002
Adenosine	2	2002	2005	July 2003
Dose-Response Relationship, Drug	2	2002	2005	July 2003
Phenethylamines	2	2002	2005	July 2003
Receptor, Adenosine A2A	2	2002	2005	July 2003
Down-Regulation	1	2005	2005	January 2005
Endothelium, Vascular	1	2005	2005	January 2005
Neovascularization, Physiologic	1	2005	2005	January 2005
Thrombospondin 1	1	2005	2005	January 2005

Victor-Vega's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (23)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors